FDA Adverse Event Injury Summary report: N

PCA PLS II

MDR report key: 3182224 · Received June 14, 2013

Report

Report Number
9615050-2013-01635
Event Type
Injury
Date Received
June 14, 2013
Date of Event
May 10, 2013
Report Date
May 16, 2013
Manufacturer
HOSPIRA COSTA RICA LTD.
Product Code
FRN
PMA / PMN Number
K912928
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION IS NOT COMPLETE. THIS REPORT REPRESENTS ALL THE INFO KNOWN BY THE REPORTER UPON QUERY BY HOSPIRA PERSONNEL.

Description of Event or Problem · 1

THE CUSTOMER CONTACT REPORTED THE PT RECEIVED MORE MEDICATION THAN INTENDED DUE TO VIAL MANIPULATION. ON AN UNSPECIFIED DATE AND TIME, THE DEVICE WAS PROGRAMMED TO DELIVER DILAUDID 1MG/ML AND THE DELIVERY WAS STARTED. NO FURTHER PROGRAMMING PARAMETERS WERE PROVIDED. ON (B)(6) 2013, AT 2150, IT WAS REPORTED THE NURSE LOADED A NEW 30ML VIAL INTO THE DEVICE AND PRIOR TO STARTING THE DELIVERY, THE NURSE VISUALLY NOTED THERE WAS ONLY 19ML IN THE VIAL INSTEAD OF THE EXPECTED 30ML. AT THAT TIME, THE VIAL WAS IMMEDIATELY REMOVED FROM THE DEVICE AND THE PT WAS TREATED WITH AN UNSPECIFIED CONCENTRATION OF ROMAZICON. AFTER AN UNSPECIFIED LENGTH OF TIME, THE CUSTOMER CONTACT INDICATED THE ROMAZICON WAS THE INCORRECT REVERSAL AGENT FOR DILAUDID AND THE PT'S OXYGEN SATURATION DECREASE TO THE MID TO HIGH 80'S. NO SPECIFIC DETAILS WERE PROVIDED. AFTER AN UNSPECIFIED LENGTH OF TIME, THE PT'S OXYGEN SATURATION RETURNED TO AN UNSPECIFIED BASELINE. THE CUSTOMER CONTACT REPORTED THAT IT WAS UNSPECIFIED IF THE TUBING WAS CLAMPED PRIOR TO CHANGING THE VIAL. THE CUSTOMER CONTACT STATED THE MISSING 11ML OF DILAUDID COULD NOT BE ACCOUNTED FOR. AFTER AN UNSPECIFIED TIME, THE DEVICE WAS REMOVED FROM CLINICAL SERVICE. THOUGH REQUESTED, NO ADDITIONAL INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
272057 PCA PLS II 80FRN FRN HOSPIRA COSTA RICA LTD. NA NA

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention DILAUDID, MFR UNK